Received: 22 March 2022
Accepted: 23 June 2022
First Online: 15 July 2022
: The GBD study used identified, aggregated data. Therefore, both the waiver of informed consent and experimental protocols were reviewed and approved by the University of Washington Institutional Review Board (application number 46665). And we confirm that all methods were performed in accordance with the relevant guidelines and regulations.The GBD study complies with the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER) statement. Further information can be found here: ExternalRef removed
: Not applicable.
: The authors declared no conflict of interests.